Pune, India, Feb. 22, 2021 (GLOBE NEWSWIRE) — The North America osteoporosis treatment market size is expected to gain momentum by reaching USD 8.29 billion by 2027 while exhibiting a CAGR of 6.6% between 2020 and 2027. This is attributable to the increasing prevalence of osteoporosis and the growing number of government approvals for the therapeutic drugs that are propelling the demand in the North America osteoporosis treatment options. Fortune Business Insights in its latest report, mentions that the market stood at USD 5.18 billion in 2019.
COVID-19 Impact: Market to Experience a Sluggish Growth at 2.3% CAGR in 2020
The COVID-19 pandemic has led to the healthcare systems and hospitals to divert their complete focus on treating people suffering from the disease. In contrast, several elective medical procedures and osteoporosis treatment appointments have either been cancelled or postponed. Based on our analysis, the North America Osteoporosis Treatment Market will exhibit a slow growth at 2.3% CAGR in 2020 due to the aforementioned reasons. However, the market will return to normalcy once the pandemic is over.
Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/sample/north-america-osteoporosis-treatment-market-104867
What does the Report Provide?
The North America Osteoporosis Treatment Market report provides an in-depth analysis of several factors such as the key drivers and restraints that will have an impact on the market. Furthermore, the report includes significant insights into the regional insights that include different regions, which are contributing to the market growth. It includes the competitive landscape involving the leading companies and the adoption of strategies by them to introduce new products, announce partnerships, collaborate, and acquire other companies that will contribute to the market growth during the forecast period. Moreover, the research analyst has adopted several research methodologies such as Porter’s five forces analysis to obtain information about the current trends and industry developments that will drive the market growth between 2020 and 2027.
Click here to get the short-term and long-term impacts of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/north-america-osteoporosis-treatment-market-104867
Presence of Established Players in the U.S. to Feed Market Growth
Geographically, the U.S market stood at USD 4.98 billion in 2019 and is expected to hold the highest position in the North American market in the forthcoming years. This is ascribable to factors such as presence of established players such as AbbVie Inc., Pfizer Inc., and Amgen Inc. that play a pivotal role in the North America osteoporosis treatment solutions development.
The market in Canada is anticipated to experience considerable growth backed by the increasing prevalence of osteoporosis and supportive government policies to educate the people regarding therapeutic treatment solutions between 2020 and 2027.
Quick Buy North America osteoporosis treatment market Research Report: https://www.fortunebusinessinsights.com/checkout-page/104867
Parenteral Segment to Showcase Exponential Growth
Based on the route by administration, the parenteral segment is expected to hold a significant North America osteoporosis treatment market share due to increasing R&D activities by the healthcare companies to develop novel parenteral drugs during the forecast period.
List of the Companies Profiled in the Market:
- AbbVie Inc. (North Chicago, Illinois, U.S.)
- Eli Lilly and Company (Indianapolis, Indiana, U.S.)
- Amgen Inc. (Thousand Oaks, California, U.S.)
- F. Hoffmann-La Roche Ltd (Basel, Switzerland)
- Novartis AG (Basel, Switzerland)
- Sanofi (Paris, France)
- Pfizer Inc. (Brooklyn, New York, U.S.)
- Merck & Co., Inc. (Kenilworth, New Jersey, U.S.)
- GlaxoSmithKline plc (Brentford, U.K)
- Alcon (Geneva, Switzerland)
- Other Prominent Player
Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/north-america-osteoporosis-treatment-market-104867
North America Osteoporosis Treatment Market Segmentation
By Drug Class
• Hormone Replacement Therapy
• Selective Estrogen Receptor Modulator (SERMs)
• RANK ligand (RANKL) Inhibitor
By Route of Administration
By Distribution Channel
• Hospitals Pharmacies
• Retail Pharmacies & Stores
• Online Pharmacies
• The U.S.
Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/north-america-osteoporosis-treatment-market-104867
Have a Look at Related Reports:
Trauma Implants Market Size, Share & Industry Analysis, By Product (Metal Plates & Screws, Pins/Wires, Nails & Rods, and Others) End-user (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and Others) and Regional Forecast, 2019-2026
Bone Growth Stimulator Market Size, Share and Industry Analysis By Product Type (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Derived Growth Factor (PDGF)), By Application (Spinal Fusion, Maxillofacial & Dental, Nonunion and Union Bone Fractures), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care), and Regional Forecast 2019-2026
Cataract Surgical Devices Market Size, Share & Industry Analysis, By Product Type (Phacoemulsification Systems, Femtosecond Laser, Intraocular Lenses, Ophthalmic Viscoelastic Devices & Other Consumables), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026
Reading Glasses Market Size, Share & Industry Analysis, By Age Group (Less than 18 years, 18-64 years, and 65 years and above), By Type (Prescription Reading Glasses and OTC Reading Glasses), By Distribution Channel (Retail Stores, Online Sales Channels, Ophthalmol-ogy Clinics), and Regional Forecast, 2019-2026
Diabetes Treatment Devices Market Size, Share & Industry Analysis, By Product (Insulin Pens, Insulin Pumps, Insulin Jet Injectors, Insulin Syringes, Others), By Distribution Channel (Institutional Sales, Retail Sales) and Regional Forecast, 2019-2026
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune – 411045, Maharashtra, India.